175 results on '"Hausmaninger, H."'
Search Results
2. Allgemeine Chirurgische Onkologie
3. Mammakarzinom
4. Maligne Lymphome
5. Nachsorge beim operierten Mammakarzinom
6. Interferonbehandlung des metastasierenden Melanoms
7. Mammakarzinom
8. Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin’s lymphoma (NHL). A multi- center trial by the Austrian Working Group For Medical Tumor Therapy
9. Abgeschlossene und derzeit laufende adjuvante Therapieprotokolle bei Patientinnen mit operablem Mammakarzinom (II)
10. Up Front Tandem High-Dose Chemotherapy Compared to Standard Chemotherapy with Doxorubicin and Paclitaxel in Metastatic Breast Cancer: Results of a Randomized Trial: O385
11. Modulation von 5-Fluorouracil durch Leucovorin bei fortgeschrittenen kolorektalen Karzinomen
12. Abgeschlossene und derzeit laufende adjuvante Therapieprotokolle bei Patienten mit operablem Mammakarzinom
13. Chemotherapie des metastasierenden Mammakarzinoms
14. Erratum to: Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin’s lymphoma (NHL). A multicenter trial by the Austrian Working Group For Medical Tumor Therapy
15. Long term results of autologous stem cell transplantation for Hodgkinʼs disease and low-/intermediate-grade non-Hodgkinʼs lymphoma: A report from the Austrian Stem Cell Transplantation Registry (ASCTR): P542
16. Randomised Trial: One Cycle of Anthracycline-Containing Adjuvant Chemotherapy Compared with Six Cycles of CMF Treatment in Node-Positive, Hormone Receptor-Negative Breast Cancer Patients
17. A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer
18. Hochdosis-Chemotherapie (HDCT) vs konventionelle Chemotherapie mit Adriamycin und Paclitaxel (AT) beim metastasierten Mammakarzinom: Ergebnisse einer randomisierten Studie: V5–8
19. A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML)
20. Nachsorge beim operierten Mammakarzinom
21. Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancer
22. Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients
23. Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon-α-2c in patients with advanced colorectal cancer: final results of a randomised phase III study
24. Etoposid in der Behandlung des inoperablen Bronchuskarzinoms
25. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow
26. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow
27. Erratum to: Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin’s lymphoma (NHL). A multicenter trial by the Austrian Working Group For Medical Tumor Therapy
28. Combination chemotherapy with aclarubicin in metastatic breast cancer
29. Rekombinantes Interferon α-2c bei Ph-positiver chronischer myeloischer Leukämie: Ergebnisse einer multizentrischen Phase-II-Studie
30. Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study
31. Toxicity and preliminary results with a new eight-drug regimen (CEOP-IMVP-DEXA) in the treatment of aggressive lymphomas
32. Up front tandem high-dose chemotherapy (HD) compared to standard chemotherapy with doxorubicin and paclitaxel (AT) in metastatic breast cancer (MBC): Final results of a randomized trial
33. 6 vs. 3 cycles of epirubicin/docetaxel + G-CSF in operable breast cancer: results of ABCSG-14
34. Phase II Study of Single-Agent Pegylated Liposomal Doxorubicin HCl (PLD) in Metastatic Breast Cancer After First-Line Treatment Failure
35. Zoledronic acid prevents bone mineral density loss in premenopausal women receiving adjuvant treatment for hormone receptor-positive breast cancer: Preliminary results of a randomized, multicenter trial of zoledronic acid in patients receiving anastrozole or tamoxifen in combination with goserelin
36. The prognostic influence of body mass index in premenopausal breast cancer patients
37. Dose related effectiveness of alpha interferon in chronic myelogenous leukemia
38. Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial
39. Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5
40. A phase II randomized study of doxorubicin (A) alternated to docetaxel (T) (ALT) vs sequential administration of 4 cy of t followed by 4 cy of a (seq) as 1st line ct in mbc pts
41. Randomized Trial of Low-Dose Chemotherapy Added to Tamoxifen in Patients With Receptor-Positive and Lymph Node–Positive Breast Cancer
42. Efficacy and toxicity of 2-chlorodeoxyadenosine (cladribine)—2h infusion for 5 days—as first-line treatment for advanced low grade non-Hodgkin’s lymphoma
43. 98 O - Tamoxifen +/- short-term chemotherapy in the treatment of node positive, hormone receptor positive breast cancer: 7-year results of a randomized trial including 517 patients
44. CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.
45. 97 P - Low dose, short-term adjuvant chemotherapy in stage I hormone receptor negative breast cancer
46. Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancer
47. 2-Chlorodesoxyadenosine: First-Line Treatment for Low-Grade Non-Hodgkin’s Lymphomas
48. 5-Fluorouracil and Folinic Acid with or without Alpha-2c Interferon in the Treatment of Metastatic Colorectal Cancer: Preliminary Results of a Multicenter Prospective Randomized Phase-Ill Trial
49. Chemotherapy of metastatic breast cancer
50. 5-Fluorouracil in Kombination mit Interferon-alpha 2c bei fortgeschrittenen Magen-Darm-Karzinomen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.